Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life.

Respir Res · 2007 · PMC1924504 · PMID 17610727

Europe PMC DOI

hedged sentence

0.1210

closest p · 2.4× alpha

0.1210

boldest claim

The sentences

did not reach statistical significancep = 0.121not close (p > 0.1)

The mean change from baseline in AQLQ overall score was numerically greater with SAL/FP than FOR/BUD at week 28 and week 52, but did not reach statistical significance (p = 0.121 at Week 52).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.